Fig. 7
From: Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
Methylation values correlated with treatment outcomes in CRC patients with matched plasma samples. A Changes in methylation ratio in stage I-III patients who had matched plasma samples before and after surgery (n = 13). B Changes in methylation ratio in stage IV patients who initially had complete response (CR), partial response (PR) or stable disease (SD) and then later had disease progression (PD) (n = 15)